Literature DB >> 23329653

Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.

Klaas N A Nagel1, Martijn G Schouten, Thomas Hambrock, Geert J S Litjens, Caroline M A Hoeks, Bennie ten Haken, Jelle O Barentsz, Jurgen J Fütterer.   

Abstract

PURPOSE: To determine if prostatitis and prostate cancer (PCa) can be distinguished by using apparent diffusion coefficients (ADCs) on magnetic resonance (MR) images, with specimens obtained at MR-guided biopsy as the standard of reference.
MATERIALS AND METHODS: The need for institutional review board approval and informed consent was waived. MR-guided biopsies were performed in 130 consecutive patients with cancer-suspicious regions (CSRs) on multiparametric MR images obtained at 3 T. In this retrospective study, 88 patients met the inclusion criteria. During the biopsy procedure, an axial diffusion-weighted sequence was performed and ADC maps were generated (repetition time msec/echo time msec, 2000/67; section thickness, 4 mm; in-plane resolution, 1.8 × 1.8 mm; and b values of 0, 100, 500, and 800 sec/mm(2)). Subsequently, a confirmation image with the needle left in situ was acquired and projected on the ADC map. The corresponding ADCs at the biopsy location were compared with the histopathologic outcomes of the biopsy specimens. Linear mixed-model regression analyses were used to test for ADC differences between the histopathologic groups.
RESULTS: The study included 116 biopsy specimens. Median ADCs of normal prostate tissue, prostatitis, low-grade PCa (Gleason grade components 2 or 3), and high-grade PCa (Gleason grade components 4 or 5) were 1.22 × 10(-3) mm(2)/sec (standard deviation, ± 0.21), 1.08 × 10(-3) mm(2)/sec (± 0.18), 0.88 × 10(-3) mm(2)/sec (± 0.15), and 0.88 × 10(-3) mm(2)/sec (± 0.13), respectively. Although the median ADCs of biopsy specimens with prostatitis were significantly higher compared with low- and high-grade PCa (P < .001), there is a considerable overlap between the tissue types.
CONCLUSION: Diffusion-weighted imaging is a noninvasive technique that shows differences between prostatitis and PCa in both the peripheral zone and central gland, although its usability in clinical practice is limited as a result of significant overlap in ADCs. RSNA, 2013

Entities:  

Mesh:

Year:  2013        PMID: 23329653     DOI: 10.1148/radiol.12111683

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  27 in total

1.  Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis.

Authors:  Meltem Esen; Mehmet Ruhi Onur; Nusret Akpolat; Irfan Orhan; Ercan Kocakoc
Journal:  Quant Imaging Med Surg       Date:  2013-08

2.  Assessment of prostate imaging reporting and data system version 2.1 false-positive category 4 and 5 lesions in clinically significant prostate cancer.

Authors:  Xiangyu Wang; Weizong Liu; Yi Lei; Guangyao Wu; Fan Lin
Journal:  Abdom Radiol (NY)       Date:  2021-03-12

3.  Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.

Authors:  Alice C Yu; Chaitra Badve; Lee E Ponsky; Shivani Pahwa; Sara Dastmalchian; Matthew Rogers; Yun Jiang; Seunghee Margevicius; Mark Schluchter; William Tabayoyong; Robert Abouassaly; Debra McGivney; Mark A Griswold; Vikas Gulani
Journal:  Radiology       Date:  2017-02-10       Impact factor: 11.105

4.  Diffusion-weighted imaging of the prostate: should we use quantitative metrics to better characterize focal lesions originating in the peripheral zone?

Authors:  Thibaut Pierre; Francois Cornud; Loïc Colléter; Frédéric Beuvon; Frantz Foissac; Nicolas B Delongchamps; Paul Legmann
Journal:  Eur Radiol       Date:  2017-11-22       Impact factor: 5.315

5.  MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.

Authors:  Lars Schimmöller; Michael Quentin; Christian Arsov; Andreas Hiester; Christian Buchbender; Robert Rabenalt; Peter Albers; Gerald Antoch; Dirk Blondin
Journal:  Eur Radiol       Date:  2014-06-28       Impact factor: 5.315

6.  Diagnostic Performance of Multiparametric MR Imaging at 3.0 Tesla in Discriminating Prostate Cancer from Prostatitis: A Histopathologic Correlation.

Authors:  Elif Peker; Didem Yasemin Sonmez; Habip Eser Akkaya; Serhat Hayme; Memet Ilhan Erden; Ayse Erden
Journal:  Eurasian J Med       Date:  2018-11-30

7.  Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.

Authors:  Ananya Panda; Gregory OʼConnor; Wei Ching Lo; Yun Jiang; Seunghee Margevicius; Mark Schluchter; Lee E Ponsky; Vikas Gulani
Journal:  Invest Radiol       Date:  2019-08       Impact factor: 6.016

8.  Quantitative contrast-enhanced perfusion kinetics in multiparametric MRI in differentiating prostate cancer from chronic prostatitis: results from a pilot study.

Authors:  Binit Sureka; Poonam Elhence; Pushpinder Singh Khera; Gautam Ram Choudhary; Himanshu Pandey; Pawan Kumar Garg; Kuldeep Yadav; Akhil Goel
Journal:  Br J Radiol       Date:  2019-06-11       Impact factor: 3.039

9.  Histologic findings associated with false-positive multiparametric magnetic resonance imaging performed for prostate cancer detection.

Authors:  Jennifer B Gordetsky; David Ullman; Luciana Schultz; Kristin K Porter; Maria Del Carmen Rodriguez Pena; Carli E Calderone; Jeffrey W Nix; Michael Ullman; Sejong Bae; Soroush Rais-Bahrami
Journal:  Hum Pathol       Date:  2018-09-01       Impact factor: 3.466

10.  Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate.

Authors:  Pieter J L De Visschere; Anne Vral; Gianpaolo Perletti; Eva Pattyn; Marleen Praet; Vittorio Magri; Geert M Villeirs
Journal:  Eur Radiol       Date:  2016-08-04       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.